Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.9000 (-1.43%) ($6.7500 - $7.0600) on Wed. May. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.26% (three month average) | RSI | 38 | Latest Price | $6.9000(-1.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.4% a day on average for past five trading days. | Weekly Trend | TGTX declines -7.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(65%) ARKG(59%) IBB(58%) ARKK(57%) IWO(57%) | Factors Impacting TGTX price | TGTX will decline at least -2.63% in a week (0% probabilities). VXX(-38%) TLT(-9%) UUP(-6%) IFRA(-6%) IGOV(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.63% (StdDev 5.26%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
1 - 5 Day Possible Target | $-6.54(-194.78%) | Resistance Level | $7.54 | 5 Day Moving Average | $6.93(-0.43%) | 10 Day Moving Average | $7.09(-2.68%) | 20 Day Moving Average | $7.54(-8.49%) | To recent high | -18.6% | To recent low | 32.9% | Market Cap | $874m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |